News Focus
News Focus
Followers 36
Posts 2263
Boards Moderated 0
Alias Born 10/18/2019

Re: alphapuppy post# 763154

Wednesday, 04/23/2025 1:18:01 PM

Wednesday, April 23, 2025 1:18:01 PM

Post# of 828417
alphpuppy, if you go by the Jama Oncology paper looking at the EAC the median survival for recurrent GBM is 7.8 months. Survival at various time periods is shown as:
12 months 30.8%
18 months 15.9%
24 months 9.6%
30 months 5.1%
I agree they may as well try dcvax as little else seems to help but imo there is not a very large group of recurrent as compared to newly diagnosed that will use the treatment, perhaps at best an equal number of recurrent as newly diagnosed. The coworker I spoke of refused a second surgery as he suffered side effects from the first surgery - at the time I had thought he might benefit from dcvax but it has taken much longer to get any approval
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News